Cargando…

Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation

Intestinal dysmotility is common in many diseases and is correlated with gut microbiota dysbiosis and systemic inflammation. Functional constipation (FC) is the most typical manifestation of intestinal hypomotility and reduces patients’ quality of life. Some studies have reported that fecal micriobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xueying, Li, Ning, Chen, Qiyi, Qin, Huanlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529243/
https://www.ncbi.nlm.nih.gov/pubmed/34690948
http://dx.doi.org/10.3389/fmicb.2021.700718
_version_ 1784586428211003392
author Zhang, Xueying
Li, Ning
Chen, Qiyi
Qin, Huanlong
author_facet Zhang, Xueying
Li, Ning
Chen, Qiyi
Qin, Huanlong
author_sort Zhang, Xueying
collection PubMed
description Intestinal dysmotility is common in many diseases and is correlated with gut microbiota dysbiosis and systemic inflammation. Functional constipation (FC) is the most typical manifestation of intestinal hypomotility and reduces patients’ quality of life. Some studies have reported that fecal micriobiota transplantation (FMT) may be an effective and safe therapy for FC as it corrects intestinal dysbiosis. This study was conducted to evaluate how FMT remodels the gut microbiome and to determine a possible correlation between certain microbes and clinical symptoms in constipated individuals. Data were retrospectively collected on 18 patients who underwent FMT between January 1, 2019 and June 30, 2020. The fecal bacterial genome was detected by sequencing the V3–V4 hypervariable regions of the 16S rDNA gene. Fecal short chain fatty acids (SCFAs) were detected by gas chromatography-mass spectrometry, and serum inflammatory factor concentrations were detected via enzyme-linked immunosorbent assay. Comparing the changes in fecal microbiome compositions before and after FMT revealed a significant augmentation in the alpha diversity and increased abundances of some flora such as Clostridiales, Fusicatenibacter, and Paraprevotella. This was consistent with the patients experiencing relief from their clinical symptoms. Abundances of other flora, including Lachnoanaerobaculum, were decreased, which might correlate with the severity of patients’ constipation. Although no differences were found in SCFA production, the butyric acid concentration was correlated with both bacterial alterations and clinical symptoms. Serum IL-8 levels were significantly lower after FMT than at baseline, but IL-4, IL-6, IL-10, and IL-12p70 levels were not noticeably changed. This study showed how FMT regulates the intestinal microenvironment and affects systemic inflammation in constipated patients, providing direction for further research on the mechanisms of FMT. It also revealed potential microbial targets for precise intervention, which may bring new breakthroughs in treating constipation.
format Online
Article
Text
id pubmed-8529243
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85292432021-10-22 Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation Zhang, Xueying Li, Ning Chen, Qiyi Qin, Huanlong Front Microbiol Microbiology Intestinal dysmotility is common in many diseases and is correlated with gut microbiota dysbiosis and systemic inflammation. Functional constipation (FC) is the most typical manifestation of intestinal hypomotility and reduces patients’ quality of life. Some studies have reported that fecal micriobiota transplantation (FMT) may be an effective and safe therapy for FC as it corrects intestinal dysbiosis. This study was conducted to evaluate how FMT remodels the gut microbiome and to determine a possible correlation between certain microbes and clinical symptoms in constipated individuals. Data were retrospectively collected on 18 patients who underwent FMT between January 1, 2019 and June 30, 2020. The fecal bacterial genome was detected by sequencing the V3–V4 hypervariable regions of the 16S rDNA gene. Fecal short chain fatty acids (SCFAs) were detected by gas chromatography-mass spectrometry, and serum inflammatory factor concentrations were detected via enzyme-linked immunosorbent assay. Comparing the changes in fecal microbiome compositions before and after FMT revealed a significant augmentation in the alpha diversity and increased abundances of some flora such as Clostridiales, Fusicatenibacter, and Paraprevotella. This was consistent with the patients experiencing relief from their clinical symptoms. Abundances of other flora, including Lachnoanaerobaculum, were decreased, which might correlate with the severity of patients’ constipation. Although no differences were found in SCFA production, the butyric acid concentration was correlated with both bacterial alterations and clinical symptoms. Serum IL-8 levels were significantly lower after FMT than at baseline, but IL-4, IL-6, IL-10, and IL-12p70 levels were not noticeably changed. This study showed how FMT regulates the intestinal microenvironment and affects systemic inflammation in constipated patients, providing direction for further research on the mechanisms of FMT. It also revealed potential microbial targets for precise intervention, which may bring new breakthroughs in treating constipation. Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529243/ /pubmed/34690948 http://dx.doi.org/10.3389/fmicb.2021.700718 Text en Copyright © 2021 Zhang, Li, Chen and Qin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Zhang, Xueying
Li, Ning
Chen, Qiyi
Qin, Huanlong
Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
title Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
title_full Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
title_fullStr Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
title_full_unstemmed Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
title_short Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
title_sort fecal microbiota transplantation modulates the gut flora favoring patients with functional constipation
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529243/
https://www.ncbi.nlm.nih.gov/pubmed/34690948
http://dx.doi.org/10.3389/fmicb.2021.700718
work_keys_str_mv AT zhangxueying fecalmicrobiotatransplantationmodulatesthegutflorafavoringpatientswithfunctionalconstipation
AT lining fecalmicrobiotatransplantationmodulatesthegutflorafavoringpatientswithfunctionalconstipation
AT chenqiyi fecalmicrobiotatransplantationmodulatesthegutflorafavoringpatientswithfunctionalconstipation
AT qinhuanlong fecalmicrobiotatransplantationmodulatesthegutflorafavoringpatientswithfunctionalconstipation